T Kobayashi1, A C Gruessner2, T Wakai3, D E R Sutherland4. 1. Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Electronic address: kobataka@med.niigata-u.ac.jp. 2. College of Public Health, University of Arizona, Tucson, Arizona, USA. 3. Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. 4. Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
PURPOSE: The purposes of this study were to study and compare clinical and functional outcomes after simultaneous deceased donor pancreas and kidney transplantation (SPK DD), simultaneous deceased donor pancreas and living donor kidney transplantation (SPK DL), and simultaneous living donor pancreas and kidney transplantation (SPK LL). METHODS: From January 1, 1996 to September 1, 2005, 8918 primary, simultaneous pancreas and kidney transplantation (SPK) procedures were reported to the International Pancreas Transplant Registry. Of these, 8764 (98.3%) were SPK DD, 115 (1.3%) were SPK DL, and 39 (0.4%) were SPK LL. We compared these 3 groups with regard to several endpoints including patient and pancreas and kidney graft survival rates. RESULTS: The 1-year and 3-year patient survival rates for SPK DD were 95% and 90%, 97% and 95% for SPK DL, and 100% and 100% for SPK LL recipients, respectively (P ≥ .07). The 1-year and 3-year pancreas graft survival rates for SPK DD were 84% and 77%, 83% and 71% for SPK DL, and 90% and 84% for SPK LL recipients, respectively (P ≥ .16). The 1-year and 3-year kidney graft survival rates for SPK DD were 92% and 84%, 94% and 86% for SPK DL, and 100% and 89% for SPK LL recipients, respectively (P ≥ .37). CONCLUSIONS: Patient survival rates and graft survival rates for pancreas and kidney were similar among the 3 groups evaluated in this study.
PURPOSE: The purposes of this study were to study and compare clinical and functional outcomes after simultaneous deceased donor pancreas and kidney transplantation (SPK DD), simultaneous deceased donor pancreas and living donor kidney transplantation (SPK DL), and simultaneous living donor pancreas and kidney transplantation (SPK LL). METHODS: From January 1, 1996 to September 1, 2005, 8918 primary, simultaneous pancreas and kidney transplantation (SPK) procedures were reported to the International Pancreas Transplant Registry. Of these, 8764 (98.3%) were SPK DD, 115 (1.3%) were SPK DL, and 39 (0.4%) were SPK LL. We compared these 3 groups with regard to several endpoints including patient and pancreas and kidney graft survival rates. RESULTS: The 1-year and 3-year patient survival rates for SPK DD were 95% and 90%, 97% and 95% for SPK DL, and 100% and 100% for SPK LL recipients, respectively (P ≥ .07). The 1-year and 3-year pancreas graft survival rates for SPK DD were 84% and 77%, 83% and 71% for SPK DL, and 90% and 84% for SPK LL recipients, respectively (P ≥ .16). The 1-year and 3-year kidney graft survival rates for SPK DD were 92% and 84%, 94% and 86% for SPK DL, and 100% and 89% for SPK LL recipients, respectively (P ≥ .37). CONCLUSIONS:Patient survival rates and graft survival rates for pancreas and kidney were similar among the 3 groups evaluated in this study.
Authors: Ngan N Lam; Mark A Schnitzler; Dorry L Segev; Gregory P Hess; Bertram L Kasiske; Henry B Randall; David Axelrod; Huiling Xiao; Amit X Garg; Daniel C Brennan; Krista L Lentine Journal: Transplantation Date: 2017-06 Impact factor: 4.939
Authors: Pedro Ventura-Aguiar; Beatriu Bayés-Genís; Antonio J Amor; Miriam Cuatrecasas; Fritz Diekmann; Enric Esmatjes; Joana Ferrer-Fàbrega; Ángeles García-Criado; Mireia Musquera; Silvia Olivella; Eva Palou; David Paredes; Sonia Perea; Anna Perez; Esteban Poch; Barbara Romano; Joan Escarrabill Journal: Transpl Int Date: 2022-04-14 Impact factor: 3.842